• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

TAVAC:对目前可用的止血产品进行全面评估,作为手术止血的辅助手段。

TAVAC: comprehensive review of currently available hemostatic products as adjunct to surgical hemostasis.

机构信息

Digestive Health Institute, AdventHealth Tampa, Tampa, FL, USA.

Stanford University, Palo Alto, CA, USA.

出版信息

Surg Endosc. 2024 May;38(5):2331-2343. doi: 10.1007/s00464-024-10806-x. Epub 2024 Apr 17.

DOI:10.1007/s00464-024-10806-x
PMID:38630180
Abstract

BACKGROUND

The use of hemostatic agents by general surgeons during abdominal operations is commonplace as an adjunctive measure to minimize risks of postoperative bleeding and its downstream complications. Proper selection of products can be hampered by marginal understanding of their pharmacokinetics and pharmacodynamics. While a variety of hemostatic agents are currently available on the market, the choice of those products is often confusing for surgeons. This paper aims to summarize and compare the available hemostatic products for each clinical indication and to ultimately better guide surgeons in the selection and proper use of hemostatic agents in daily clinical practice.

METHODS

We utilized PubMed electronic database and published product information from the respective pharmaceutical companies to collect information on the characteristics of the hemostatic products.

RESULTS

All commercially available hemostatic agents in the US are described with a description of their mechanism of action, indications, contraindications, circumstances in which they are best utilized, and expected results.

CONCLUSION

Hemostatic products come with many different types and specifications. They are valuable tools to serve as an adjunct to surgical hemostasis. Proper education and knowledge of their characteristics are important for the selection of the right agent and optimal utilization.

摘要

背景

普通外科医生在腹部手术中使用止血剂作为辅助措施来尽量减少术后出血及其下游并发症的风险是很常见的。由于对其药代动力学和药效学的了解有限,产品的正确选择可能会受到阻碍。虽然目前市场上有多种止血剂,但对于外科医生来说,选择这些产品往往令人困惑。本文旨在总结和比较每种临床适应证的可用止血产品,并最终更好地指导外科医生在日常临床实践中选择和正确使用止血剂。

方法

我们利用 PubMed 电子数据库和各制药公司发布的产品信息收集止血剂产品特性的信息。

结果

美国所有市售的止血剂均描述了其作用机制、适应证、禁忌证、最佳应用情况和预期效果。

结论

止血剂有许多不同的类型和规格。它们是作为外科止血辅助手段的有价值的工具。适当的教育和对其特性的了解对于选择正确的制剂和最佳利用是很重要的。

相似文献

1
TAVAC: comprehensive review of currently available hemostatic products as adjunct to surgical hemostasis.TAVAC:对目前可用的止血产品进行全面评估,作为手术止血的辅助手段。
Surg Endosc. 2024 May;38(5):2331-2343. doi: 10.1007/s00464-024-10806-x. Epub 2024 Apr 17.
2
[Local hemostatic agent - fluid active hemostatic matrix].[局部止血剂 - 流体活性止血基质]
Khirurgiia (Mosk). 2019(5):104-115. doi: 10.17116/hirurgia2019051104.
3
Management of surgical hemostasis: topical agents.手术止血的管理:局部用药
Vascular. 2008 Mar-Apr;16 Suppl 1:S22-8.
4
Systematic review of hemostatic agents used in vascular surgery.血管外科用止血剂的系统评价。
J Vasc Surg. 2021 Jun;73(6):2189-2197. doi: 10.1016/j.jvs.2020.10.081. Epub 2020 Nov 27.
5
Evaluation of the topical hemostatic efficacy and safety of TISSEEL VH S/D fibrin sealant compared with currently licensed TISSEEL VH in patients undergoing cardiac surgery: a phase 3, randomized, double-blind clinical study.在心脏手术患者中比较TISSEEL VH S/D纤维蛋白密封剂与目前已获许可的TISSEEL VH的局部止血疗效和安全性评估:一项3期随机双盲临床研究。
J Cardiovasc Surg (Torino). 2007 Jun;48(3):323-31.
6
[Analysis of opinion of surgeons on the role of topical hemostatic agents].[外科医生关于局部止血剂作用的观点分析]
Khirurgiia (Mosk). 2020(8):61-68. doi: 10.17116/hirurgia202008161.
7
Comparison of hemostatic properties between collagen and synthetic buttress materials used in staple line reinforcement in a swine splenic hemorrhage model.比较猪脾出血模型中用于钉线加固的胶原与合成加强板材料的止血性能。
Surg Endosc. 2011 Apr;25(4):1148-52. doi: 10.1007/s00464-010-1331-4. Epub 2010 Sep 11.
8
Topical hemostatic agents in oral surgery: a narrative review.口腔外科中的局部止血剂:一篇叙述性综述。
Eur Rev Med Pharmacol Sci. 2023 Apr;27(3 Suppl):135-140. doi: 10.26355/eurrev_202304_31332.
9
Hemostasis in oral surgery.口腔外科中的止血
Dent Clin North Am. 2012 Jan;56(1):17-23, vii. doi: 10.1016/j.cden.2011.06.004. Epub 2011 Oct 7.
10
Topical Hemostatic Agents at Time of Obstetric and Gynecologic Surgery: ACOG Committee Opinion, Number 812.产科和妇科手术时使用的局部止血剂:ACOG 委员会意见,第 812 号。
Obstet Gynecol. 2020 Oct;136(4):e81-e89. doi: 10.1097/AOG.0000000000004104.

引用本文的文献

1
Hemostatic Benefits of an Absorbable Polysaccharide Powder in Redo Cardiac Surgery: A Comparative Study.可吸收多糖粉末在心脏再次手术中的止血益处:一项对比研究。
Med Devices (Auckl). 2025 Jul 3;18:377-386. doi: 10.2147/MDER.S509115. eCollection 2025.

本文引用的文献

1
Topical haemostatic agents in surgery.外科手术中的局部止血剂。
Br J Surg. 2024 Jan 3;111(1). doi: 10.1093/bjs/znad361.
2
Impact of preoperative red blood cell transfusion on long-term mortality of liver transplantation: A retrospective cohort study.术前红细胞输血对肝移植后长期死亡率的影响:一项回顾性队列研究。
Medicine (Baltimore). 2023 Sep 15;102(37):e34914. doi: 10.1097/MD.0000000000034914.
3
Pre-operative anemia and peri-operative transfusion are associated with poor oncologic outcomes in cancers of the esophagus: potential impact of patient blood management on cancer outcomes.
术前贫血和围手术期输血与食管肿瘤的不良肿瘤学结果相关:患者血液管理对肿瘤结局的潜在影响。
BMC Cancer. 2023 Jan 28;23(1):99. doi: 10.1186/s12885-023-10579-x.
4
Efficacy, safety, and physicochemical properties of a flowable hemostatic agent made from absorbable gelatin sponge via vacuum pressure steam sterilization.经真空压力蒸汽灭菌的可吸收明胶海绵制成的流动性止血剂的功效、安全性和理化性质。
J Biomater Appl. 2021 Feb;35(7):776-789. doi: 10.1177/0885328220950899. Epub 2020 Aug 24.
5
Perioperative management of the bleeding patient.围手术期出血患者的管理。
Br J Anaesth. 2016 Dec;117(suppl 3):iii18-iii30. doi: 10.1093/bja/aew358.
6
A multicentre, prospective, randomized, controlled trial comparing EVARREST™ fibrin sealant patch to standard of care in controlling bleeding following elective hepatectomy: anatomic versus non-anatomic resection.一项多中心、前瞻性、随机对照试验,比较EVARREST™纤维蛋白封闭剂贴片与标准治疗方法在择期肝切除术后控制出血中的效果:解剖性切除与非解剖性切除。
HPB (Oxford). 2016 Mar;18(3):221-8. doi: 10.1016/j.hpb.2015.12.006. Epub 2016 Feb 1.
7
Fibrin Sealant Patch (TachoSil) vs Oxidized Regenerated Cellulose Patch (Surgicel Original) for the Secondary Treatment of Local Bleeding in Patients Undergoing Hepatic Resection: A Randomized Controlled Trial.纤维蛋白封闭剂贴片(TachoSil)与氧化再生纤维素贴片(Surgicel Original)用于肝切除患者局部出血的二次治疗:一项随机对照试验
J Am Coll Surg. 2016 Mar;222(3):261-8. doi: 10.1016/j.jamcollsurg.2015.12.007. Epub 2015 Dec 18.
8
Central venous pressure and liver resection: a systematic review and meta-analysis.中心静脉压与肝切除术:一项系统评价与荟萃分析
HPB (Oxford). 2015 Oct;17(10):863-71. doi: 10.1111/hpb.12462. Epub 2015 Aug 20.
9
Results from a First-in-Human Trial of a Novel Vascular Sealant.新型血管密封剂首次人体试验结果
Front Surg. 2015 Jul 1;2:29. doi: 10.3389/fsurg.2015.00029. eCollection 2015.
10
Oxidized regenerated cellulose resembling vaginal cuff abscess.类似阴道残端脓肿的氧化再生纤维素。
JSLS. 2014 Apr-Jun;18(2):353-6. doi: 10.4293/108680813X13693422518597.